Replace Andrew? This year, the CEO and his team, supported by C2MI, IRAP/NRC, and ISED, have made significant steps. They have applied for three new patents and are working towards a product agreement with a named partner. Additionally, they are progressing with sample production, as previously announced.
Remarkably, Andrew, the sole employee, has achieved these milestones with minimal funding and manpower.
As an investor this aligns with what I am aiming for in leadership. Replacing Andrew would be asinine.